OncoDNA
Latest round
- Series C
Last raised
- Jun 2023
Total raised
- $19M
Investors
- 11
About OncoDNA
Founded in 2012 by François Blondel, and Jean-Pol Detiffe, and based in Gosselies, Belgium, OncoDNA SA is a medical diagnostic company that develops precision medicines for the treatment of cancer and other genetic diseases. The firm’s services include translational research, drug development, patient testing and treatment, monitoring, and reimbursement through collaborations and partnerships with various healthcare providers and institutions. The company explores and interprets genetic data collected of patients to deliver precision medicine to treat cancer and other genetic diseases in humans.
Who invested in OncoDNA
11 investors across 2 rounds
See all investors in OncoDNA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about OncoDNA
Who invested in OncoDNA?
OncoDNA has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OncoDNA raised?
OncoDNA has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did OncoDNA last raise money?
OncoDNA's most recent round on record is a Series C, in Jun 2023.
What does OncoDNA do?
Founded in 2012 by François Blondel, and Jean-Pol Detiffe, and based in Gosselies, Belgium, OncoDNA SA is a medical diagnostic company that develops precision medicines for the treatment of cancer and other genetic diseases.
Where is OncoDNA headquartered?
OncoDNA is headquartered in Belgium.
Which VCs invest in companies like OncoDNA?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at OncoDNA's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like OncoDNA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.